Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE
- Phentermine/Topiramate as Preventive Pharmacotherapy for Obesity
- Phentermine/Topiramate in Adolescents With Type 2 Diabetes and Obesity
- Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients
- Pharmacotherapy for Pediatric Obesity: A Phentermine Clinical Trial
- Obesity and Uric Acid Stones Study
- Comparing a Virtual vs. Face to Face Weight Management Program Using Phentermine for Patients With Overweight or Obesity
- Treatment of Obesity With Topiramate in Patients With Polycystic Ovary Syndrome
- Anti-Obesity Phentermine-Topiramate Extended Release Pharmacotherapy vs Placebo Among Patients Using a Wearable Activity Tracker
- Role of Pharmacotherapy in Counteracting Weight Regain in Adolescents With Severe Obesity
- Adjunct Phentermine + Topiramate After Bariatric Surgery in 12-24 Year Olds
- SMART Use of Medication for the Treatment of Adolescent Severe Obesity
- Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)
- Fixed Dose Combination of Fluoxetin and Metformin in the Management of Overweight and Obesity
- Phentermine/Topiramate Extended Release in Binge Eating Disorder (BED)
- EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)
- FDA Approved Medication to Reduce Binge Eating and/or Purging
- Topiramate-Phentermine Combinations for Cocaine Dependence
- Effect of VI-0521 (Qsymia®) on Glomerular Filtration Rate (GFR) in Overweight or Obese Healthy Subjects
- Peripheral Pharmacodynamics of Phentermine-Topiramate in Obese Patients
- A Drug Interaction Study of VI-0521 With Metformin, Sitagliptan and Probenecid in Healthy Subjects.
- A Study to Evaluate the Pharmacokinetics of VI-0521 Subjects With Renal Impairment
- Open-Label Study to Evaluate the Long-Term Safety and Efficacy of VI-0521 in Type 2 Diabetic Adults
- A VI-0521 Study to Evaluate the Long-term Safety and Efficacy in Type 2 Diabetic Adults
- A Study Comparing Multiple Doses of VI-0521 With Placebo and Their Single-agent Constituents for Treatment of Obesity in Adults
- Pharmacokinetic Comparison of Multiple Formulations of Topiramate and Phentermine in Obese Adults
Clinical trials list
click for details